Monday, 24 September, 2018

(CELG) is Brave Asset Management Inc.'s 4th Largest Position

Nellie Chapman | 08 February, 2018, 13:01

The hedge fund held 2,431 shares of the restaurants company at the end of 2017Q3, valued at $810,000, up from 1,460 at the end of the previous reported quarter. The company's market cap is $76.19 Billion, and the average volume is $6.95 Million. About 38.12 million shares traded or 145.04% up from the average.

Celgene Corporation (NASDAQ:CELG) now has a "Sell" signals on Composite indicators by TrendSpotter. It has outperformed by 0.30% the S&P500. The stock decreased 6.09% or $0.19 during the last trading session, reaching $2.93. The institutional investor held 21,220 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $3.09M, up from 9,390 at the end of the previous reported quarter. The company has a market capitalization of $94.92 billion, a PE ratio of 37.58 and a beta of 1.88. The stock decreased 1.48% or $0.08 during the last trading session, reaching $5.32. Ecolab Inc. (NYSE:ECL) has risen 9.41% since February 7, 2017 and is uptrending. It has underperformed by 11.80% the S&P500. It also increased its holding in Edwards Lifesciences Corp (Put) (NYSE:EW) by 5,000 shares in the quarter, for a total of 35,000 shares, and has risen its stake in Bio Rad Labs Inc (NYSE:BIO).

Since August 10, 2017, it had 0 buys, and 3 insider sales for $2.84 million activity.

Investors sentiment increased to 1.9 in Q3 2017. Its down 0.02, from 1.04 in 2017Q2. It improved, as 31 investors sold ECL shares while 274 reduced holdings. 147.06 million shares or 7.33% less from 158.68 million shares in 2017Q2 were reported. The company has market cap of $458.10 million. Qci Asset Ny owns 2,500 shares for 0% of their portfolio. One National Association has invested 0.02% in Ecolab Inc. Kepos LP invested in 4,805 shares. 335,429 were accumulated by Cheyne Cap Mgmt (Uk) Llp. Suffolk Capital Ltd Liability Company accumulated 36,004 shares. 140,569 are held by Asset One. (NYSE:ECL). 71,276 are held by Cim Limited Co. (NYSE:NLY). Thompson Management reported 41,195 shares or 0.09% of all its holdings. Welch And Forbes Ltd Liability Corp invested in 47,797 shares or 0.18% of the stock. Contravisory Mngmt holds 102 shares or 0.01% of its portfolio. (NYSE:NLY) for 18,324 shares. Payden & Rygel invested 0.01% of its portfolio in Ecolab Inc. Sequoia Fincl Advsrs Lc owns 4,353 shares.

A 17 analysts rate it as either a buy or a strong buy, while1 believe that investors should either steer clear of CELG or, if they already own its stock, sell it. Therefore 50% are positive. The firm issued an outperform rating and a $162.00 price target on the biopharmaceutical company's stock. The firm has "Overweight" rating given on Wednesday, February 24 by Barclays Capital. On Wednesday, January 27 the stock rating was downgraded by Sidoti to "Neutral". Morgan Stanley reinitiated Nokia Corporation (NYSE:NOK) on Tuesday, February 16 with "Equal-Weight" rating. Oppenheimer maintained Celgene Corporation (NASDAQ:CELG) rating on Monday, October 30. As per Thursday, January 25, the company rating was maintained by Guggenheim. Canaccord Genuity maintained it with "Buy" rating and $15600 target in Tuesday, June 6 report. On Wednesday, October 5 the stock rating was maintained by Jefferies with "Buy". The insider MARIO ERNEST sold 18,506 shares worth $2.42M.

Celgene Corporation (CELG) analysts on average have given a price target of $124.51 on CELG stock. Therefore 55% are positive.

CELG has been the subject of several analyst reports. Mark Sheptoff Planning Ltd holds 0.02% in Celgene Corporation (NASDAQ:CELG) or 158 shares. The stock has "Buy" rating by Robert W. Baird on Thursday, September 28. The rating was maintained by Mizuho with "Buy" on Monday, February 5. The firm earned "Buy" rating on Friday, January 26 by BTIG Research. Cantor Fitzgerald reiterated a "hold" rating and set a $112.00 price target on shares of Celgene in a report on Monday, January 29th. UBS maintained it with "Buy" rating and $120 target in Friday, October 27 report. The company was maintained on Thursday, September 7 by Piper Jaffray. (NYSE:NLY) earned "Underperform" rating by Bank of America on Thursday, December 15. 603.99 million shares or 0.25% more from 602.51 million shares in 2017Q2 were reported. About 6.76M shares traded.

Investors sentiment decreased to 1.17 in 2017 Q3. The low EPS estimate is $0.99, while the high EPS estimate is $1.2. The stock grabbed 118 new institutional investments totaling 9,514,844 shares while 109 institutional investors sold out their entire positions totaling 4,995,309 shares. 133 funds opened positions while 451 raised stakes. Mason Street Advsr Lc reported 34,322 shares or 0.02% of all its holdings. Return on Assets (ROA) value of the stock is 11.4 Percent. Icon Advisers holds 132,260 shares or 1.35% of its portfolio. 115,300 were accumulated by Symphony Asset Ltd Liability Company. Boston Family Office Ltd Liability Co stated it has 135,238 shares. State Board Of Administration Of Florida Retirement System owns 1.52 million shares or 0.05% of their USA portfolio. Kentucky Retirement Insurance Tru Fund reported 0.53% stake. Robecosam Ag, a Switzerland-based fund reported 800 shares. Contravisory Invest Mngmt Inc holds 102 shares. BMO Capital Markets dropped their target price on Celgene from $163.00 to $148.00 and set an "outperform" rating for the company in a research note on Friday, October 27th. Sun Life Fincl invested in 628 shares or 0.01% of the stock. Old National Savings Bank In reported 61,154 shares.